putting our experience towards helping people heal

Clay and Danielle Fette have a unique combined experience in the medical device and biopharmaceutical industries.

Clay is a brilliant engineer and a pioneer in tissue regeneration with over 20 patents. He has previously worked with other extracellular matrix (ECM) technologies such as small intestine submucosa (SIS) and urinary bladder matrix (UBM).

Danielle is a nurse and an incredible patient advocate with an entrepreneurial spirit. She has worked in the medical device and biopharmaceutical fields for start-ups and fortune 500 companies. She has 25 years of global experience in sales and marketing.

Together they have an excellent aptitude for identifying challenges and developing creative solutions that enhance the healing process. Based on their experience with previous technologies, they developed the Multi-Tissue Platform (MTP), the first and only ECM technology to include more than one source tissue.

Stemsys, a FetTech company provides innovative solutions to address unmet needs in current medical technology.  The company is committed to the development of high quality, safe, and cost-effective solutions that significantly improve patient outcomes.

StemSys MTP Technology

The multi-tissue platform (MTP) was developed to combine multiple ECM materials in varying ratios to allow for customization of desired components in the final biomaterial device and facilitate site specific healing and tissue regeneration.  There are an almost endless number of possible combinations of ECMs that can be designed for site specific defects and applications.   

Each ECM material is composed of a unique combination of several components, such as:

  • PROTEINS AND GLYCOSAMINOGLYCANS (GAGS):

  • COLLAGEN

  • LAMININ

  • ELASTIN

  • FIBRONECTIN

  • EXOSOMES

GROWTH FACTORS:

  • FIBROBLAST GROWTH FACTOR (FGF)

  • VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)

  • EPIDERMAL GROWTH FACTOR (EGF)

  • PLATELET DERIVED GROWTH FACTOR (PDGF)

XCelliStem® Wound Powder

XCelliStem Wound Powder is a proprietary blend utilizing multiple extracellular matrix materials derived from the multi-tissue platform (MTP).  Rather than one single biomolecule, a number of different components work together to facilitate healing and repair.  

The proprietary technology platform can provide a custom blend of these components for advanced wound healing applications. StemSys combines multiple ECM materials in varying ratios to allow for customization of desired components in the final biomaterial device and facilitates site specific healing and tissue regeneration.